Ebola case numbers reach 426 in the current outbreak in the Democratic Republic of Congo, making this the second largest ever seen for the virus.
Browsing: Emerging Disease
A new trial has begun in the Democratic Republic of Congo, aiming to collect robust data on the safety and efficacy of investigational Ebola therapeutics.
Take a look behind the scenes of a recent Future Virology paper as we ask author Prof. Mohamed El Zowalaty about the challenges facing the field of arboviruses, from climate change to urbanization, both in South Africa and across the world.
The US FDA has granted priority review for Sanofi Pasteur’s dengue vaccine, Dengvaxia®, despite its controversial past.
A team from the Okinawa Institute of Science and Technology Graduate University has used cryo-EM to model the nucleocapsid protein of Ebola virus, potentially uncovering novel drug targets.
The first citywide deployment of Wolbachia has proved successful, with no dengue cases reported since Wolbachia became established.
Following a study that shed new light on the psychiatric and neurological problems suffered by Ebola survivors, researchers are calling for more specialist support for this population.